We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
+3.5%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$49.2B
AUM Growth
-$9.2B
(-16%)
Cap. Flow
-$11.4B
Cap. Flow
% of AUM
-23.18%
Top 10 Holdings %
Top 10 Hldgs %
69.17%
Holding
102
New
6
Increased
15
Reduced
40
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$154M |
| 2 |
Martin Marietta Materials
MLM
|
+$139M |
| 3 |
Vulcan Materials
VMC
|
+$121M |
| 4 |
GE Aerospace
GE
|
+$71.4M |
| 5 |
Expedia Group
EXPE
|
+$68.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$332M |
| 2 |
ASML
ASML
|
+$182M |
| 3 |
argenx
ARGX
|
+$158M |
| 4 |
Carlyle Group
CG
|
+$152M |
| 5 |
Ross Stores
ROST
|
+$132M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.41% |
| 2 | Consumer Discretionary | 6.7% |
| 3 | Communication Services | 5.44% |
| 4 | Financials | 3.04% |
| 5 | Materials | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Ross Stores
ROST
$81.9B
| $108M | 0.22% |
713,133
-900,000
| -56% | -$132M |
|
52
Sherwin-Williams
SHW
$89.8B
| $104M | 0.21% |
306,970
| – | – |
|
53
Sarepta Therapeutics
SRPT
$1.77B
| $104M | 0.21% |
853,845
+220,000
| +35% | +$27M |
|
54
KE Holdings
BEKE
$18.8B
| $92.6M | 0.19% |
5,025,999
-6,000,000
| -54% | -$124M |
|
55
S&P Global
SPGI
$120B
| $84.4M | 0.17% |
169,548
| – | – |
|
56
New Oriental
EDU
$8.98B
| $83.7M | 0.17% |
1,303,597
-260,000
| -17% | -$16.7M |
|
57
American Tower
AMT
$80.4B
| $78.6M | 0.16% |
428,730
| – | – |
|
58
NVIDIA
NVDA
$5.42T
| $77.2M | 0.16% |
574,953
-100,000
| -15% | -$13.8M |
|
|
XYZ
59
Block Inc
XYZ
$47.5B
| $73.6M | 0.15% |
866,200
-700,000
| -45% | -$57.4M |
|
60
Ultragenyx Pharmaceutical
RARE
$2.55B
| $71M | 0.14% |
1,686,716
-1,325,000
| -44% | -$65.7M |
|
|
BPMC
61
DELISTED
Blueprint Medicines
BPMC
| $69.8M | 0.14% |
800,628
+81,700
| +11% | +$7.48M |
|
62
CALL
3M
MMM
$94.3B
| $65.8M | 0.13% |
+510,000
| New | +$66.9M |
|
63
PUT
Amazon
AMZN
$2.96T
| $65.8M | 0.13% |
300,000
-450,000
| -60% | -$92.1M |
|
64
Rhythm Pharmaceuticals
RYTM
$7.96B
| $65.4M | 0.13% |
1,167,700
| – | – |
|
65
PUT
Meta Platforms (Facebook)
META
$1.51T
| $64.4M | 0.13% |
110,000
-105,000
| -49% | -$61.6M |
|
66
Yum! Brands
YUM
$41.1B
| $62.5M | 0.13% |
465,951
| – | – |
|
67
Chipotle Mexican Grill
CMG
$41.5B
| $60.4M | 0.12% |
1,001,250
| – | – |
|
68
PUT
TSMC
TSM
$2.18T
| $59.2M | 0.12% |
300,000
-50,000
| -14% | -$9.68M |
|
69
BioCryst Pharmaceuticals
BCRX
$2.4B
| $53.3M | 0.11% |
7,093,822
| – | – |
|
70
Astera Labs
ALAB
$58B
| $53M | 0.11% |
400,000
+150,000
| +60% | +$14.1M |
|
71
UiPath
PATH
$7.8B
| $51.6M | 0.11% |
4,061,276
| – | – |
|
|
AKRO
72
DELISTED
Akero Therapeutics
AKRO
| $49M | 0.1% |
1,761,268
-1,563,736
| -47% | -$47.4M |
|
|
73
PUT
NVIDIA
NVDA
$5.42T
| $48.3M | 0.1% |
360,000
-100,000
| -22% | -$13.8M |
|
|
74
argenx
ARGX
$54.1B
| $46.1M | 0.09% |
75,000
-270,000
| -78% | -$158M |
|
75
Cintas
CTAS
$81.3B
| $43.2M | 0.09% |
236,716
| – | – |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Alkeon Capital Management held 102 positions worth $49.2B, down 16% from $58.3B the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Alkeon Capital Management withdrew a net $11.4B in Q4 2024, closing 7 positions and reducing 40 holdings. Its most notable exit was Elastic, an estimated $54M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Alkeon Capital Management opened a new position in StandardAero Inc worth $40.1M.
- Alkeon Capital Management's largest Q4 2024 buy was StandardAero Inc: 1,620,000 shares worth $40.1M.
- Alkeon Capital Management added most to Lam Research in Q4 2024, an estimated $154M increase.
- Alkeon Capital Management's biggest Q4 2024 reduction was Applied Materials, cutting an estimated $332M.
- Alkeon Capital Management fully exited Elastic in Q4 2024, selling an estimated $54M.
- Alkeon Capital Management's ten largest holdings make up 69% of its $49.2B portfolio in Q4 2024.
- Alkeon Capital Management opened 6 new positions and closed 7 in Q4 2024.
- Alkeon Capital Management's portfolio value fell 16% quarter-over-quarter to $49.2B.
Based on Alkeon Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.